Why the study?
Studies using Kv1.3 knockout animal models needed to be summarized and compared with pharmacological modulation findings to understand channel function in vivo across various pathophysiological settings.
Key points are not available for this paper at this time.
Population
Kv1.3 knockout animal models
Comparison
Kv1.3 knockout animal models vs pharmacological modulation of Kv1.3
Design
Review
Kv1.3 modulation of cell processes remains preclinical; leaves open cardiovascular relevance in humans.
Potassium channels are widespread over all kingdoms and play an important role in the maintenance of cellular ionic homeostasis. Kv1.3 is a voltage-gated potassium channel of the Shaker family with a wide tissue expression and a well-defined pharmacology. In recent decades, experiments mainly based on pharmacological modulation of Kv1.3 have highlighted its crucial contribution to different fundamental processes such as regulation of proliferation, apoptosis, and metabolism. These findings link channel function to various pathologies ranging from autoimmune diseases to obesity and cancer. In the present review, we briefly summarize studies employing Kv1.3 knockout animal models to confirm such roles and discuss the findings in comparison to the results obtained by pharmacological modulation of Kv1.3 in various pathophysiological settings. We also underline how these studies contributed to our understanding of channel function in vivo and propose possible future directions.
No takes yet. Share an insight, caveat, or question.
Varanita et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: